Clinical Trial Update: Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults [Phase 2]

View source ↗

Summary

This Phase 2 trial of the device RD047-26 for mild to moderate atopic dermatitis in adults has completed, focusing on efficacy and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Pruritus

Drugs mentioned

• RD047-26

Snippet

Sponsor: Oculus Innovative Sciences, Inc. | Conditions: Atopic Dermatitis, Pruritus | Phase 2 | Status: COMPLETED